News

The study consisted of a blinded, randomized clinical trial involving 46 dogs recruited from the public. The animals were randomly assigned to receive either the Oximunol supplement (0.5mg/kg

The company said that the Human Inflammation Cytokine Assay pairs the DPN-deposited protein arrays with a protocol that can be conducted on the lab bench without any instrumentation.

Denis Corin, president of TapImmune, said: “We are proud to team with Aeras in the search for the next generation of vaccines to eliminate the scourge of tuberculosis

The phase IIa trial was a randomised, double-blind, placebo-controlled, cross-over study in 24 parkinson’s patients using doses up to 120mg/day for one week. The effects of SYN-115 as

The company said that its new facility provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility. Robin Smith, chairman and CEO of NeoStem, said: “This

The company said that the protocol provides a simple, three-step testing algorithm that can be customized based upon a patient’s symptoms and history. Step one provides a screen

The collaborative sites are expected to provide clinical expertise and samples to evaluate the clinical utility of a microRNA (miRNA) test, based on FNA biopsies, to distinguish pancreatic

The company said that the researchers are expected to conduct gene expression research in the areas of advanced lung disease and asthma and will use the SmartChip system

CS-8958 is a laninamivir prodrug that is a Long-Acting Neuraminidase Inhibitor. The drug, developed entirely for the Japanese market by Daiichi Sankyo, will be in the form of